Elisa Pizzolato - Publications

Multicystic peritoneal mesothelioma mimicking recurrent pseudomyxoma peritonei.

Journal: Journal of surgical case reports

Published: March 29, 2026

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal malignancies: a monocentric, single-arm open-label phase II clinical trial.

Journal: Surgical oncology

Published: July 08, 2025

National Guidelines for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Malignancies: A Worldwide Systematic Review and Recommendations of Strength Analysis.

Journal: Annals of surgical oncology

Published: March 25, 2025

Clinical benefits of symptom resolution after palliative surgery in advanced cancer: A single-center experience.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: February 27, 2024

Systemic Chemotherapy in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery: Systematic Review and Meta-Analysis.

Journal: Cancers

Published: February 07, 2024

Doxorubicin as Risk Factor for Fascial Dehiscence After CRS-HIPEC for Peritoneal Metastases.

Journal: Anticancer research

Published: January 23, 2024

Laparoscopic Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis: Improved Short-term Outcomes Revealed Through Propensity Score Matching Analysis.

Journal: Journal of gastrointestinal cancer

Published: January 07, 2024

Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases.

Journal: ESMO open

Published: December 20, 2023

Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis.

Journal: Annals of surgical oncology

Published: February 28, 2023

Colorectal Cancer with Peritoneal Metastases: The Impact of the Results of PROPHYLOCHIP, COLOPEC, and PRODIGE 7 Trials on Peritoneal Disease Management.

Journal: Cancers

Published: November 07, 2022

HIPEC as a risk factor for postoperative coagulopathy after cytoreductive surgery for peritoneal metastases.

Journal: Updates in surgery

Published: December 22, 2021

Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases of colorectal origin - A Video Vignette.

Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Published: September 29, 2021